Biogen submits Plegridy BLA for MS

Biogen Idec Inc. (NASDAQ:BIIB) submitted a BLA to FDA for Plegridy peginterferon beta-1a ( BIIB017) to treat relapsing forms of multiple sclerosis (MS). The company said it expects to submit MAA to EM...